US Drug Recall Register

FDA Drug Recalls

1,739 recalls · Class I, newest first

Class I · High risk Terminated

Vancomycin Hydrochloride for Injection

Reason Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.

Hospira Inc., A Pfizer Company NDC 0409-6510-01 D-0638-2017
Class I · High risk Terminated

Nano PNC Water

Reason Marketed without an Approved NDA/ANDA and non-sterility: NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.

Pacific Medical Solutions D-0505-2017
Class I · High risk Terminated

SLIMFIT X capsules

Reason Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.

Jersey Shore Supplements, LLC D-0473-2017
Class I · High risk Terminated

MegaJex Herbal Supplement

Reason Marketed without an Approved NDA/ANDA; product contains sildenafil and tadalafil which are active pharmaceutical ingredients in FDA approved drugs used to treat erectile dysfunction (ED)

MS Bionic D-0472-2017
Class I · High risk Terminated

Domperidone capsules 10 mg

Reason Marketed without an approved NDA/ANDA for which safety and efficacy has not been established.

Jeffreys Drug Store D-0494-2017
Class I · High risk Terminated

Ultimate Body Tox PRO capsules

Reason Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.

Ultimate Body Tox D-0210-2017
Class I · High risk Terminated

Skinny Bee Diet capsules

Reason Marketed without an approved NDA/ANDA: presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and phenolphthalein.

Love My Tru Body D-0223-2017
Class I · High risk Terminated

Lidocaine HCL/ Sodium Bicarb

Reason Non-Sterility: failed sterility test result.

Guardian Pharmacy Services D-0211-2017
Class I · High risk Terminated

GlucaGen HypoKit

Reason Defective delivery system: detached needles on the syringe in the kit.

Novo Nordisk Inc NDC 0169-7065-15 D-0217-2017
Class I · High risk Terminated

Eye Wash

Reason Non-Sterility: Direct evidence of contamination for 2 lots based on FDA samples.

United Exchange Corporation NDC 0904-6491-20 D-0496-2017
Class I · High risk Terminated

Hyoscyamine Sulfate

Reason Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.

Virtus Pharmaceuticals Opco II L NDC 76439-308-10 D-0214-2017
Class I · High risk Terminated

Hyoscyamine Sulfate

Reason Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.

Virtus Pharmaceuticals Opco II L NDC 76439-307-10 D-0213-2017
Class I · High risk Terminated

Hyoscyamine Sulfate

Reason Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.

Virtus Pharmaceuticals Opco II L NDC 76439-309-10 D-0212-2017
Class I · High risk Terminated

Lamotrigine Orally Disintegrating Tablets

Reason Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs

Impax Laboratories, Inc. D-0215-2017
Class I · High risk Ongoing

Bupivacaine Hydrochloride Inj.

Reason Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.

Hospira Inc., A Pfizer Company NDC 0409-1159-02 D-0218-2017
Class I · High risk Terminated

Comfort Shield

Reason Microbial Contamination of Non-Sterile Products: contamination with the bacteria, Burkholderia cepacia.

Sage Products LLC NDC 53462-915-50 D-0229-2017
Class I · High risk Terminated

Docusate Oral 10 mg/mL Oral Syringe

Reason Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia

US Compounding Inc D-0219-2017
Class I · High risk Terminated

Cetylev

Reason Defective Container: Incomplete seal on blister packaging, leading to tablet swelling and enlarging due to effervescence process beginning as oxygen and moisture enter the blister packaging.

Arbor Pharmaceuticals Inc. NDC 24338-700-10 D-0105-2017
Class I · High risk Terminated

Diocto Liquid

Reason Microbial contamination of Non-Sterile Products; positive findings of Burkholderia cepacia

The Harvard Drug Group NDC 0536-0590-85 D-0022-2017